In vitro stimulation with HBV therapeutic vaccine candidate Nasvac activates B and T cells from chronic hepatitis B patients and healthy donors-Reference-Cited by-同舟云学术

In vitro stimulation with HBV therapeutic vaccine candidate Nasvac activates B and T cells from chronic hepatitis B patients and healthy donors

Published:2015-02 Issue:2 Volume:63 Page:320-327
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Lobaina Yadira,Hardtke Svenja,Wedemeyer Heiner,Aguilar Julio Cesar,Schlaphoff Verena

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference30 articles.

1. Cellular and Molecular Immunology;Abbas,2012

2. Development of a nasal vaccine for chronic hepatitis infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen;Aguilar;Immunol. Cell Biol.,2004

3. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens;Aguilar-Betancourt;Int. J. Infect. Dis.,2007

4. Immune modulator and antiviral potential of dendritic cells pulsed with both hepatitis B surface antigen and core antigen for treating chronic HBV infection;Akbar;Antiviral Ther.,2010

5. A phase III clinical trial with a therapeutic vaccine containing both HBsAg and HBcAg administered via both mucosal and parenteral routes in patients with chronic hepatitis B;Akbar;Hepatology,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparing for the Next Pandemic: Increased Expression of Interferon-Stimulated Genes After Local Administration of Nasalferon or HeberNasvac;DNA and Cell Biology;2023-12-21

2. Developments in pharmacotherapeutic agents for hepatitis B – how close are we to a functional cure?;Expert Opinion on Pharmacotherapy;2023-05-15

3. Immune response induced by recombinant pres2/S-protein and a pres2-S-protein fused with a core 18-27 antigen fragment of hepatitis B virus compared to conventional HBV vaccine;Virus Genes;2023-05-04

4. Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B;Vaccines;2022-12-07

5. Photodynamic Therapy in Combination with the Hepatitis B Core Virus-like Particles (HBc VLPs) to Prime Anticancer Immunity for Colorectal Cancer Treatment;Cancers;2022-05-31